Abstract
A study was made of the composition and biochemical behaviour of the drug, Laetrile, distributed for clinical trial in the United States and Canada. It was established that the Canadian and the American product are different pharmaceutical formulations, displaying different physicochemical and biochemical properties. The investigation demonstrated, furthermore, that neither preparation can be considered as a palliative in cancer therapy on the basis of the biological rationale advanced by their manufacturers.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- LEVI L., WALKER G. C., PUGSLEY L. I. QUALITY CONTROL OF PHARMACEUTICALS. Can Med Assoc J. 1964 Oct 10;91:781–785. [PMC free article] [PubMed] [Google Scholar]